ArticleCancer gene therapy2023

Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis.

Mingliang Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.